- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for Medivation Inc (MDVN)
| Open: | 48.3800 | Day's Range: | 47.2700 - 48.9900 | Volume: | 1,324,600 |
|---|---|---|---|---|---|
| Previous Close: | 48.2900 | 52wk Range: | 39.3550 - 59.2400 | 1-Yr Rtn: | +14.32% |
Key Statistics for MDVN
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -0.9250 |
| Est. EPS (USD) (12/2013) | -1.0290 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 3,563.65 |
| Shares Outstanding (M) | 74.98 |
| 30 Day Average Volume | 996,521 |
| Price/Book (mrq) | 62.9725 |
| Price/Sale (ttm) | 18.3893 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend (USD) | 4.5000 |
| Last Dividend | 07/27/1999 |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/09/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for MDVN
Company Profile & Key Executives for MDVN
Medivation Inc. acquires, develops, and sells or partners biomedical technologies in the early development stage of the research and development process.
| David T HungPresident/CEO/Co-Founder | C Patrick MachadoCFO/Chief Bus Ofcr |
| Cheryl CohenChief Commercial Officer | Jennifer J RhodesChief Compliance Ofcr/Secy/Gen Cnsl |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
MDVN News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page